Method of treating aortic aneurysm using muse cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11419899
APP PUB NO 20190175662A1
SERIAL NO

16321203

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A cell product for prevention and/or treatment of vascular disorders such as aortic aneurysm, comprising a SSEA-3-positive pluripotent stem cell derived from a mesenchymal tissue in a living body or a cultured mesenchymal cell (Muse cell).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TOHOKU UNIVERSITYSENDAI-SHI MIYAGI 980-8577

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dezawa, Mari Sendai, JP 54 242
Hosoyama, Katsuhiro Sendai, JP 1 0
Saiki, Yoshikatsu Sendai, JP 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 23, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 23, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 23, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00